Expression of B4GALNT1, an essential glycosyltransferase for the synthesis of complex gangliosides, suppresses BACE1 degradation and modulates APP processing.
Alzheimer's disease (AD) is the most prevalent form of dementia characterized by the extracellular accumulation of amyloid β (Aβ) peptides, which are produced by proteolytic cleavages of amyloid precursor protein (APP). Gangliosides are involved in AD pathophysiology including Aβ deposition and APP processing, yet the detailed mechanisms are not fully understood. Here we examined how changes in the carbohydrate moiety of gangliosides alter APP processing in human melanoma cells, neuroectoderm-derived cells. We showed that forced expression of GD2, GM2 or GM1 (by introducing B4GALNT1 cDNA into cells not expressing this glycosyltransferase) results in increases of α- and β-site cleavages of APP with a prominent increase in β-cleavage. We also showed that β-site APP cleaving enzyme 1 (BACE1) protein is highly protected from the degradation in cells expressing these gangliosides, thereby increasing the expression of this protein. Unexpectedly, adding gangliosides exogenously altered neither BACE1 levels nor β-site cleavage. The stabilisation of BACE1 protein led to the increase of this protein in lipid rafts, where BACE1 processes APP. Based on the current results, we propose a hitherto undisclosed link between ganglioside expression and AD; the expression of B4GALNT1 positively regulates the β-site cleavage by mainly inhibiting the lysosomal degradation of BACE1 protein.
Department of Biochemistry II, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.
Tokiaki
T
Yamaguchi
Department of Biochemistry II, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.
Yoshio
Y
Yamauchi
Department of Biomedical Sciences, Chubu University College of Life and Health Science, Kasugai 487-8501, Japan.
Keiko
K
Furukawa
Department of Biochemistry II, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.
Yuhsuke
Y
Ohmi
Department of Biochemistry II, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.|Department of Biomedical Sciences, Chubu University College of Life and Health Science, Kasugai 487-8501, Japan.
Yuki
Y
Ohkawa
Department of Biochemistry II, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.
Qing
Q
Zhang
Department of Biochemistry II, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.
Tetsuya
T
Okajima
Department of Biochemistry II, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.|Department of Biomedical Sciences, Chubu University College of Life and Health Science, Kasugai 487-8501, Japan.
Koichi
K
Furukawa
J Lipid Res. 2009 Apr;50 Suppl:S440-5
18845618
Neurochem Res. 2012 Jun;37(6):1185-91
22488331
N Engl J Med. 2010 Jan 28;362(4):329-44
20107219
Neuron. 2007 Jun 7;54(5):721-37
17553422
Biochim Biophys Acta. 2008 Mar;1780(3):513-9
18078823
Neurobiol Aging. 2005 Jun;26(6):833-8
15718041
J Biol Chem. 1997 Oct 3;272(40):24794-9
9312075
PLoS One. 2012;7(3):e34095
22470521
FASEB J. 2010 Aug;24(8):2783-94
20354142
Nat Med. 2004 Sep;10 (9):959-65
15286784
Neuron. 2014 Apr 16;82(2):308-19
24685176
J Cell Biol. 2003 Jan 6;160(1):113-23
12515826
J Neurosci. 2011 Feb 2;31(5):1837-49
21289194
Cold Spring Harb Perspect Med. 2012 Jan;2(1):a006304
22315713
FASEB J. 2004 Oct;18(13):1571-3
15289451
Mol Biol Cell. 2012 Jun;23(12):2339-51
22553349
Neurochem Int. 1992 Apr;20(3):433-8
1304338
Semin Cell Dev Biol. 2004 Aug;15(4):389-96
15207829
Arch Biochem Biophys. 2001 Apr 15;388(2):225-30
11368158
J Lipid Res. 2008 Jun;49(6):1157-75
18334715
J Biol Chem. 1997 Sep 26;272(39):24536-41
9305918
Mol Psychiatry. 2004 Oct;9(10):946-52
15052275
J Immunol. 1989 Feb 1;142(3):848-54
2464027
Nat Rev Mol Cell Biol. 2010 Oct;11(10):688-99
20861879
J Invest Dermatol. 1996 Oct;107(4):543-8
8823358
J Biol Chem. 1992 Jun 15;267(17):12082-9
1601877
Neurobiol Aging. 2009 Nov;30(11):1777-91
18258340
Cell. 2012 Mar 16;148(6):1204-22
22424230
Nat Med. 1995 Oct;1(10):1062-6
7489364
Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11041-6
16040804
EMBO Mol Med. 2015 Jan 15;7(2):175-89
25592972
J Neurosci. 2012 Nov 14;32(46):16243-55a
23152608
Arch Neurol. 2002 Sep;59(9):1381-9
12223024
Anal Biochem. 1996 May 15;237(1):24-9
8660532
J Neurosci. 2006 Dec 6;26(49):12838-46
17151287
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):E559-68
21825135
J Biol Chem. 2005 Mar 25;280(12):11696-703
15615712
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3632-7
14978286
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22405-10
20018737
Arch Neurol. 1989 Apr;46(4):398-401
2705899
Neurobiol Dis. 2011 Jul;43(1):176-83
21440067
J Lipid Res. 2016 Jan;57(1):77-88
26497474
J Neurochem. 2012 Jan;120 Suppl 1:62-70
22122349
J Neurochem. 1994 Mar;62(3):1039-47
8113790
J Neurochem. 2010 Feb;112(4):1045-53
19968762
Cancer Res. 2001 May 15;61(10):4244-52
11358851
J Biol Chem. 2004 Oct 22;279(43):44945-54
15322084
Mol Neurobiol. 2017 Jan;54(1):623-638
26748510
Biochem J. 1999 Sep 15;342 Pt 3:633-40
10477274
J Neurochem. 2012 Mar;120(6):869-80
22171895
Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12147-52
9770454
N Engl J Med. 2012 Aug 30;367(9):795-804
22784036
J Biol Chem. 2005 Jul 29;280(30):28110-7
15923191
Curr Biol. 2001 Aug 21;11(16):1288-93
11525745
J Biol Chem. 2005 Sep 16;280(37):32499-504
16033761
Arch Neurol. 1991 Oct;48(10):1032-5
1929894
J Neurochem. 2014 Jul;130(1):4-28
24646365